Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1, Single Dose Escalation Study to Investigate the Use of Delayed Release Tablets for Colonic Delivery of Brilacidin in Healthy Volunteers

NCT04240223 is registered in ClinicalTrials.gov with Innovation Pharmaceuticals, Inc. as lead sponsor.

NCT NCT04240223
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04240223 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1, Single Dose Escalation Study to Investigate the Use of Delayed Release Tablets for Colonic Delivery of Brilacidin in Healthy Volunteers
Lead sponsor
Innovation Pharmaceuticals, Inc.
Phase
Phase 1
Overall status
Completed
Start date
January 6, 2020
Completion date
February 12, 2020
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteers